Medication Abortion Up to 70 Days of Gestation
ACOG’s clinical practice bulletin provides evidence-based guidelines on medication abortion for pregnancies up to 70 days gestation, including protocols and safety considerations.
ACOG’s clinical practice bulletin provides evidence-based guidelines on medication abortion for pregnancies up to 70 days gestation, including protocols and safety considerations.
This resource offers internal medicine physicians an updated overview of medication abortion practices in 2024, highlighting key clinical considerations and guidelines.
This resource from the Society for Maternal Fetal Medicine explains federal activities and litigation activity impacting medical emergencies and the application of EMTALA in the context of abortion care access.
Review this article for an in-depth analysis of the impact of state abortion restrictions on healthcare access and outcomes, highlighting changes to the physician workforce post-Dobbs.
This paper reviews state policies limiting the use of criminal records in medical licensing decisions.
The Repro Legal Helpline offers legal support and guidance to patients facing questions or challenges related to abortion laws.
This JAMA article published by Reingold et al. discusses the legal challenges and ethical dilemmas that clinicians face in providing reproductive care after the Dobbs decision, including risk of legal penalties, concerns with privacy, and approaches to miscarriage management.
This guide educates healthcare providers on their rights and legal protections, including how to respond to a subpoena for information on reproductive healthcare services.
This document from AAFP, AAP, ACOG, and ACP addresses the impact of legislative interference on physicians' ability to provide reproductive care and announces principles to improve access to care.
This AMA statement to a U.S. House of Representatives Subcommittee details the organization’s position on abortion and reproductive health during a 2022 congressional hearing.